Neo Ivy Capital Management’s Encompass Health EHC Stock Holding History

Neo Ivy Capital Management’s Portfolio EHC Stock Details EHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-55	Closed	-$5.84K	–	385
2025 Q4	$5.84K	Buy	+55	New	+$6.38K	﹤0.01%	329
2022 Q3	–	Sell	-3,146	Closed	-$140K	–	424
2022 Q2	$140K	Sell	3,146 -288	-8%	-$14.8K	0.37%	85
2022 Q1	$194K	Buy	+3,434	New	+$179K	0.18%	204
2021 Q4	–	Sell	-2,643	Closed	-$130K	–	483
2021 Q3	$130K	Sell	2,643 -5,817	-69%	-$366K	0.15%	211
2021 Q2	$525K	Buy	+8,460	New	+$564K	0.53%	52
2021 Q1	–	Sell	-3,772	Closed	-$248K	–	509
2020 Q4	$248K	Buy	3,772 +3,400	+914%	+$200K	0.28%	128
2020 Q3	$19K	Sell	372 -2,271	-86%	-$117K	0.02%	416
2020 Q2	$130K	Buy	+2,643	New	+$143K	0.15%	211
2019 Q2	–	Sell	-27,698	Closed	-$1.29M	–	309
2019 Q1	$1.29M	Buy	27,698 +21,591	+354%	+$1.09M	0.73%	46
2018 Q4	$300K	Buy	+6,107	New	+$347K	0.24%	174

Other funds holding EHC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Neo Ivy Capital Management's EHC Position: Q1 2026 in Review

Neo Ivy Capital Management sold out of Encompass Health (EHC) in Q1 2026, closing a stake of 55 shares — an estimated $5.84K sold.

Neo Ivy Capital Management first reported a position in EHC in Q4 2018 and held it in 10 quarters. The position peaked at $1.29M in Q1 2019. 577 funds tracked by Wall St. Rank hold EHC as of Q1 2026.

Neo Ivy Capital Management reported no remaining Encompass Health position as of Q1 2026 after selling out during the quarter.
Neo Ivy Capital Management sold 55 Encompass Health shares in Q1 2026, an estimated $5.84K.
Neo Ivy Capital Management first reported a position in Encompass Health in Q4 2018 and held it in 10 quarters.
Neo Ivy Capital Management's Encompass Health position peaked at $1.29M in Q1 2019.
577 funds tracked by Wall St. Rank held Encompass Health as of Q1 2026.

Based on Neo Ivy Capital Management's 13F filing for Q1 2026, filed 15 May 2026.